Home
About Odylia
- Our Mission
- Our Story
- Our Team
- Our Partners
- News
- Contact Us
Our Path
Resources
Consortium
- Consortium Position and Goals

Home
About Odylia
- Our Mission
- Our Story
- Our Team
- Our Partners
- News
- Contact Us
Our Path
Resources
Consortium
- Consortium Position and Goals

Pipeline

Scientist in laboratory looking through a microscope

RPGRIP1
USH1C
USH2A
RDH12
CLRN1

Questions? We’re here to help!

Services

Services
Our Path
Consortium

Studies

Strategy
Pipeline
Clinical Trials
Disease Targets

Advocacy

Our Mission
Resources
Gene Therapy 101
Other Resources

Latest News

Odylia co-founder Luk Vandenberghe talks to Nature about bioengineered viruses and the Odylia (non)-business model.
Odylia CSO speaks to the Charles River World Congress
Odylia CEO speaks at NIH/NCATS conference (video)

© 2018 Odylia Therapeutics | Terms, Conditions & Privacy | Web Site by Hester Designs LLC.